AstraZeneca Elated On Calquence Data, IMGN's IMGN632 Appears To Be Promising In AML, XRTX On Watch
13/12 07:57
(RTTNews) - Today's Daily Dose brings you news about AstraZeneca's new long-term data related to cancer drug Calquence; superior efficacy of Novartis' Scemblix compared to Bosulif in chronic myeloid leukemia; and ImmunoGen's updated initial safety and efficacy findings from its p...